Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA.

导出 OA

翻译打印收藏纠错

作者： Leihong,Wu ^[1] ; Taylor,Ingle ^[1] ; Zhichao,Liu ^[1] ; Anna,Zhao-Wong ^[2] ; Stephen,Harris ^[1] ; Shraddha,Thakkar ^[1] ; Guangxu,Zhou ^[1] ; Junshuang,Yang ^[1] ; Joshua,Xu ^[1] ; Darshan,Mehta ^[1] ; Weigong,Ge ^[1] ; Weida,Tong ^[3] ; Hong,Fang ^[4]

作者单位： National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. ^[1] MedDRA Maintenance and Support Services Organization, 7575 Colshire Dr., McLean, VA, 22102, USA. ^[2] National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. Weida.Tong@fda.hhs.gov. ^[3] National Center for Toxicological Research, U.S. Food and Drug Administration, Jefferson, AR, 72079, USA. Hong.Fang@fda.hhs.gov. ^[4]

关键词 Adverse drug reactions Boxed Warning Data mining Drug labeling Drug safety MedDRA Standard terminology Structured product labeling

主题词药物副反应报告系统(Adverse Drug Reaction Reporting Systems);数据挖掘(Data Mining);药物标签(Drug Labeling);人类(Humans)

DOI 10.1186/s12859-019-2628-5

PMID 30871458

发布时间 2020-02-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交